Kazegrow-F Solution is a topical formulation containing Minoxidil 5% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult males. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle cells, thereby prolonging the anagen phase of the hair cycle. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combination therapy targets multiple pathogenic mechanisms of male pattern baldness, offering improved efficacy compared to monotherapy. Kazegrow-F Solution is applied topically to the affected scalp areas once daily, ensuring localized action with minimal systemic absorption. Clinical studies have demonstrated significant improvement in hair density and thickness with consistent use over several months. Patients should be advised regarding potential side effects, including scalp irritation, itching, and rare systemic effects related to Finasteride. Use is contraindicated in women and children, and caution is advised in patients with hypersensitivity to any component. Regular follow-up is recommended to assess therapeutic response and monitor for adverse reactions. Kazegrow-F Solution provides a clinically effective option for managing male androgenetic alopecia with a well-established safety profile.